publication date: Jun. 9, 2017

In Brief Ben Melson rejoins MD Anderson as chief financial officer

Ben Melson will become the institution’s senior vice president and chief financial officer at MD Anderson Cancer Center.

Melson previously worked at MD Anderson for six years, mostly as CFO, before moving to Texas Children’s Hospital, the nation’s largest pediatric health care system. There he oversaw operating revenue growth from $900 million to more than $3 billion over 12 years.

“I’m extremely optimistic about the future and the trajectory of MD Anderson,” Melson said in a statement. “We’ll continue to lead the nation in cancer care and cancer research, and will do so in a financially responsible manner as this wonderful institution continues Making Cancer History and serving many future generations.”

Among his accomplishments at Texas Children’s Hospital are: developing and implementing an enterprise risk management tool, aggregating the purchasing efforts of 30 freestanding children’s hospitals across the U.S., negotiating more than $700 million in tax-exempt bond and debt transactions, creating and maintaining a strategic financial plan known as the Economic Forecasting Model, and directing multiple academic affiliation negotiations with Baylor College of Medicine.


Jeffrey Molter named director of communications at NYU Perlmutter Cancer Center

Jeffrey Molter joined NYU Langone Medical Center in a newly-created position of director of cancer center communications of its Laura and Isaac Perlmutter Cancer Center. Molter comes to Perlmutter after serving … Continue reading Ben Melson rejoins MD Anderson as chief financial officer

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.